Mirae Asset Global Investments’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90K | Buy |
34,095
+9,663
| +40% | +$25.5K | ﹤0.01% | 1159 |
|
|
2025
Q1 | $76.7K | Buy |
24,432
+1,211
| +5% | +$3.8K | ﹤0.01% | 1159 |
|
|
2024
Q4 | $64.6K | Sell |
23,221
-1,971
| -8% | -$5.48K | ﹤0.01% | 1229 |
|
|
2024
Q3 | $99K | Buy |
25,192
+4,545
| +22% | +$17.9K | ﹤0.01% | 1184 |
|
|
2024
Q2 | $135K | Sell |
20,647
-38,764
| -65% | -$254K | ﹤0.01% | 1105 |
|
|
2024
Q1 | $319K | Buy |
59,411
+17,549
| +42% | +$94.2K | ﹤0.01% | 2085 |
|
|
2023
Q4 | $210K | Buy |
41,862
+31,143
| +291% | +$156K | ﹤0.01% | 2320 |
|
|
2023
Q3 | $18.1K | Sell |
10,719
-21,870
| -67% | -$37K | ﹤0.01% | 2564 |
|
|
2023
Q2 | $90.6K | Buy |
32,589
+5,815
| +22% | +$16.2K | ﹤0.01% | 2540 |
|
|
2023
Q1 | $48.7K | Sell |
26,774
-24,669
| -48% | -$44.9K | ﹤0.01% | 2512 |
|
|
2022
Q4 | $261K | Sell |
51,443
-7,231
| -12% | -$36.7K | ﹤0.01% | 2209 |
|
|
2022
Q3 | $292K | Sell |
58,674
-13,003
| -18% | -$64.7K | ﹤0.01% | 2176 |
|
|
2022
Q2 | $2.34M | Buy |
71,677
+48,770
| +213% | +$1.59M | 0.01% | 1094 |
|
|
2022
Q1 | $129K | Buy |
22,907
+6,896
| +43% | +$38.8K | ﹤0.01% | 1556 |
|
|
2021
Q4 | $98K | Buy |
+16,011
| New | +$98K | ﹤0.01% | 1550 |
|